Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

IBB vs FBIOX overlap: 34% of top holdings shared

Bottom line

How much do IBB and FBIOX overlap?

34% of their top holdings overlap by weight. 9 securities appear in both funds' top 25, making up 32.8% of IBB's assets and 23.7% of FBIOX's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

IBBFBIOX
Weight overlap (top 25)34%
Shared holdings9
Weight in shared holdings32.8%23.7%
Total positions254215
Expense ratio0.44%0.62%
Holdings as ofSep 30, 2025May 31, 2026

Source: SEC Form N-PORT (periods Sep 30, 2025 / May 31, 2026)

Holdings IBB and FBIOX have in common

Holding% of IBB% of FBIOXOverlap
Gilead Sciences, Inc.7.52%4.82%4.82%
Amgen, Inc.7.50%6.53%6.53%
Alnylam Pharmaceuticals, Inc.5.68%2.93%2.93%
Argenx SE3.15%2.25%2.25%
Insmed, Inc.2.95%2.25%2.25%
Natera, Inc.2.11%1.41%1.41%
Biogen, Inc.2.03%1.26%1.26%
Madrigal Pharmaceuticals, Inc.0.92%0.93%0.92%
Moderna, Inc.0.88%1.28%0.88%

Source: SEC Form N-PORT (periods Sep 30, 2025 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in IBB

  1. BlackRock Funds III — 13.18%
  2. Vertex Pharmaceuticals, Inc. — 7.66%
  3. Regeneron Pharmaceuticals, Inc. — 5.70%
  4. IQVIA Holdings, Inc. — 3.18%
  5. Mettler-Toledo International, Inc. — 2.49%
  6. BeOne Medicines Ltd. — 2.11%
  7. United Therapeutics Corp. — 1.82%
  8. Waters Corp. — 1.77%
  9. Incyte Corp. — 1.62%
  10. Illumina, Inc. — 1.41%
  11. Genmab A/S — 1.38%
  12. Neurocrine Biosciences, Inc. — 1.34%
  13. Medpace Holdings, Inc. — 1.16%
  14. Exelixis, Inc. — 1.07%
  15. Ionis Pharmaceuticals, Inc. — 1.03%

Only in FBIOX

  1. Krystal Biotech Inc — 10.58%
  2. Abbvie Inc — 9.22%
  3. Fidelity Revere Street Trust — 3.35%
  4. Praxis Precision Medicines Inc. — 2.47%
  5. Ascendis Pharma A/s — 2.04%
  6. Revolution Medicines Inc — 2.02%
  7. Ucb Sa — 2.00%
  8. Jazz Pharmaceuticals Plc — 1.84%
  9. Scholar Rock Holding Corp — 1.55%
  10. Axsome Therapeutics Inc — 1.28%
  11. Protagonist Therapeutics Inc — 1.15%
  12. Roivant Sciences Ltd — 1.13%
  13. Cogent Biosciences Inc — 1.07%
  14. Tango Therapeutics Inc — 0.98%
  15. Celcuity Inc — 0.95%

Asset mix

Asset typeIBBFBIOX
Stocks99.8%99.0%
Cash & short-term funds13.4%3.5%
Preferred stock—0.9%

Source: SEC Form N-PORT (periods Sep 30, 2025 / May 31, 2026)

Country mix

CountryIBBFBIOX
US98.6%88.5%
NL4.3%2.9%
CH2.7%1.1%
DK2.2%2.6%
BE—2.0%
IE0.5%2.0%
BM0.7%1.1%
GB1.0%0.8%

Source: SEC Form N-PORT (periods Sep 30, 2025 / May 31, 2026)

Check another pair

FAQ

How much do IBB and FBIOX overlap?
About 34% by weight. 9 securities appear in both funds' top 25 holdings; they make up 32.8% of IBB's assets and 23.7% of FBIOX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do IBB and FBIOX have in common?
The largest shared holdings are Amgen, Inc., Gilead Sciences, Inc., Alnylam Pharmaceuticals, Inc., Insmed, Inc., Argenx SE.
Should I own both IBB and FBIOX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, IBB or FBIOX?
IBB is broader, with 254 positions versus 215 for FBIOX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.